Tofacitinib
NDC 60505-4858, tofacitinib, tablet, film coated, extended release, from Apotex Corp..
- Product NDC
- 60505-4858
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220458
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4858 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-4858-3 | 60505485803 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-4858-3) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dd62a2b8-300b-d92b-7b27-a30eaa68fdd3NADAC price for package 60505485803
GET /v1/drugs/nadac/60505485803
Use it
Look up 60505-4858 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4858 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-4858. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.